CC BY-NC-ND 4.0 · Asian J Neurosurg 2021; 16(01): 221-227
DOI: 10.4103/ajns.AJNS_287_20
Case Report

“When the Benign Bleed” vestibular schwannomas with clinically significant intratumoral hemorrhage: A case series and review of the literature

Peter Woo
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Pak-Lun Lam
1   Department of Diagnostic and Interventional Radiology, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Yuki Ip
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Timothy Chan
2   Department of Anatomical Pathology, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Oliver Ng
2   Department of Anatomical Pathology, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Marco Kwan
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Hoi-Tung Wong
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Alain Wong
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
,
Kwong-Yau Chan
Department of Neurosurgery, Kwong Wah Hospital, Yau Ma Tei, Hong Kong
› Author Affiliations

Vestibular schwannomas (VSs) are slow-growing benign neoplasms commonly located at the cerebellopontine angle. Although clinically significant hemorrhagic VSs are rarely encountered with only 75 patients previously reported, they could be life threatening. We discuss the presentation and outcomes of three patients with hemorrhagic VS as well as review the literature for this phenomenon. Consecutive adult patients with a histologically proven diagnosis of VS over a 9-year period were retrospectively reviewed. Fifty adult patients were identified with three (6%) having clinically significant intratumoral hemorrhage. This was defined as patients having acute to subacute symptoms with frank radiological evidence of hemorrhage. The mean age of diagnosis was 62 ± 9 years and the male-to female ratio was 2:1. The mean duration of symptoms, namely headache, vertigo, and sensorineural hearing impairment, was 26 ± 4 days with one patient presenting with acute coma. Retrosigmoid craniotomy for tumor resection was performed for all patients. Histopathological examination revealed extensive areas of microhemorrhage with considerable macrophage infiltration. All three patients were discharged with no additional neurological deficit and good functional performance. Clinically significant hemorrhagic VSs are rare, and patients may present with acute to subacute (i.e., within a month) symptoms of hearing loss headache, facial, or trigeminal nerve palsy. Macrophage infiltration is frequently encountered in tumor specimens and reflects the pivotal role of chronic inflammation in their pathophysiology. Surgical resection can lead to good outcomes with timely intervention.

Financial support and sponsorship

Nil.




Publication History

Received: 10 June 2020

Accepted: 29 July 2020

Article published online:
16 August 2022

© 2021. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Carlson ML, Link MJ, Wanna GB, Driscoll CL. Management of sporadic vestibular schwannoma. Otolaryngol Clin North Am 2015;48:407-22.
  • 2 Asari S, Katayama S, Itoh T, Tsuchida S, Furuta T, Ohmoto T. Neurinomas presenting as spontaneous intratumoral hemorrhage. Neurosurgery 1992;31:406-11.
  • 3 Niknafs YS, Wang AC, Than KD, Etame AB, Thompson BG, Sullivan SE. Hemorrhagic vestibular schwannoma: Review of the literature. World Neurosurg 2014;82:751-6.
  • 4 Dehdashti AR, Kiehl TR, Guha A. Vestibular schwannomas presenting with haemorrhage: Clinical presentation and histopathological evaluation of an unusual entity. Br J Neurosurg 2009;23:431-6.
  • 5 Nikolopoulos TP, Fortnum H, O'donoghue G, Baguley D. Acoustic neuroma growth: A systematic review of the evidence. Otol Neurotol 2010;31:478-85.
  • 6 House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-7.
  • 7 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982;5:649-55.
  • 8 Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): Clinical presentation. Neurosurgery 1997;40:1-9.
  • 9 Carlson ML, Tombers NM, Driscoll CL, van Gompel JJ, Lane JI, Raghunathan A, et al. Clinically significant intratumoral hemorrhage in patients with vestibular schwannoma. Laryngoscope 2017;127:1420-6.
  • 10 Mathkour M, Helbig B, Mccormack E, Amenta PS. Acute presentation of vestibular schwannoma secondary to intratumoral hemorrhage: A case report and literature review. World Neurosurg 2019;129:157-63.
  • 11 Pinna MH, Bento RF, Neto RV. Vestibular schwannoma: 825 cases from a 25-year experience. Int Arch Otorhinolaryngol 2012;16:466-75.
  • 12 Kim SH, Youm JY, Song SH, Kim Y, Song KS. Vestibular schwannoma with repeated intratumoral hemorrhage. Clin Neurol Neurosurg 1998;100:68-74.
  • 13 Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Yang I, Pitts LH, et al. Intratumoral hemorrhage and fibrosis in vestibular schwannoma: A possible mechanism for hearing loss. J Neurosurg 2011;114:386-93.
  • 14 Moscovici S, Limb R, Azriel A, Briggs R, Hall N, Kaye AH. Repeated spontaneous intra-tumoural and subarachnoid haemorrhage in an anticoagulated patient with a previously-irradiated vestibular schwannoma: Case report. J Clin Neurosci 2020;73:323-5.
  • 15 Brady AP, Stack JP. Case report: Magnetic resonance demonstration of haemorrhagic acoustic neuroma. Clin Radiol 1994;49:61-3.
  • 16 Ohta S, Yokoyama T, Nishizawa S. Massive haemorrhage into acoustic neurinoma related to rapid growth of the tumour. Br J Neurosurg 1998;12:455-7.
  • 17 Park CK, Kim DC, Park SH, Kim JE, Paek SH, Kim DG, et al. Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas. J Neurosurg 2006;105:576-80.
  • 18 Piccirillo E, Wiet MR, Flanagan S, Dispenza F, Giannuzzi A, Mancini F, et al. Cystic vestibular schwannoma: Classification, management, and facial nerve outcomes. Otol Neurotol 2009;30:826-34.
  • 19 Sugihara S, Kinoshita T, Matsusue E, Fujii S, Ogawa T. Multicystic acoustic schwannoma with intratumoral hemorrhage: A report of two cases. Magn Reson Med Sci 2004;3:101-4.
  • 20 Moon KS, Jung S, Seo SK, Jung TY, Kim IY, Ryu HH, et al. Cystic vestibular schwannomas: A possible role of matrix metalloproteinase-2 in cyst development and unfavorable surgical outcome. J Neurosurg 2007;106:866-71.
  • 21 Nissinen L, Kahari VM. Matrix metalloproteinases in inflammation. Biochim Biophys Acta 2014;1840:2571-80.
  • 22 de Vries M, Hogendoorn PC, Briaire-de Bruyn I, Malessy MJ, van der Mey AG. Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Arch 2012;460:629-36.
  • 23 de Vries M, Briaire-de Bruijn I, Malessy MJ, de Bruïne SF, van der Mey AG, Hogendoorn PC. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas. Otol Neurotol 2013;34:347-52.
  • 24 Cayé-Thomasen P, Werther K, Nalla A, Bøg-Hansen TC, Nielsen HJ, Stangerup SE, et al. Vegf and vegf receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005;26:98-101.
  • 25 Koutsimpelas D, Stripf T, Heinrich UR, Mann WJ, Brieger J. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics. Otol Neurotol 2007;28:1094-9.
  • 26 Lewis D, Roncaroli F, Agushi E, Mosses D, Williams R, Li KL, et al. Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma. Neuro Oncol 2019;21:314-25.
  • 27 Tos M, Stangerup SE, Caye-Thomasen P, Tos T, Thomsen J. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 2004;130:216-20.
  • 28 Gagliardo C, Martines F, Bencivinni F, La Tona G, Lo Casto A, Midiri M. Intratumoral haemorrhage causing an unusual clinical presentation of a vestibular schwannoma. Neuroradiol J 2013;26:30-4.
  • 29 Ganslandt O, Fahrig A, Strauss C. Hemorrhage into cystic vestibular schwannoma following stereotactic radiation therapy. Zentralbl Neurochir 2008;69:204-6.
  • 30 Ghobashy A, Loveren H. Acoustic schwannoma presenting as acute posterior fossa hematoma: Case report and review of the literature. Skull Base Surg 1993;3:136-40.
  • 31 Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): The facial nerve-preservation and restitution of function. Neurosurgery 1997;40:684-94.
  • 32 Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: A systematic review of complications by approach. Neurosurg Focus 2012;33:E14.